10, 2024 — A scientific team has created a preclinical blood test to identify adults most likely to develop severe respiratory conditions, including chronic obstructive pulmonary disease (COPD).

In 2021,138,825 people died from COPD in the U.S., making it the sixth overall leading cause of death and the fifth ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to ...

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

AZD-6793 is under clinical development by AstraZeneca and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

They display ... Second Phase 3 Clinical Trial Again Shows Dupilumab Lessens Disease in COPD Patients With Type 2 Inflammation May 20, 2024 — Chronic obstructive pulmonary disease patients with ...

Dr Rajeev Jayadevan, chairman of Kerala State IMA Research Cell, says it is very common in young children and there is no ...

Low birth weight is associated with an increased risk of chronic obstructive pulmonary disease (COPD), particularly among ...

Amid the recent outbreak of Human Metapneumovirus (HMPV) in China, an expert from the Indian Medical Association (IMA) on Sat ...

There are many different ways lifestyle diseases can be classified or grouped. Here is the way I like to group them: (1) ...